Clinical Trials Browser

Interventional × bemcentinib × CNS × Clear all

Mesothelioma, Malignant, COVID-19, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Melanoma, Myelodysplastic Syndromes, Pancreatic Neoplasms, Leukemia, Myeloid, Acute

NCT03965494 2024-02-08

AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery

Phase EARLY_PHASE1 Terminated

10 enrolled

CNS

Glioblastoma, Central Nervous System Neoplasms

Clinical Trials

8479217

AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery